Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2010
The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth
Calin O Marian, Steve K Cho, Brian M McEllin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening
Pasi A Jänne, Ana M Borras, Yanan Kuang, et al.
Cancer Research
|
November 23, 2006
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities
Elizabeth A Maher, Cameron Brennan, Patrick Y Wen, et al.
Journal of Neuro-Oncology
|
April 20, 2017
Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis
Timothy E Richardson, Matija Snuderl, Jonathan Serrano, et al.
Cancer Cell
|
June 28, 2002
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis
Robert M Bachoo, Elizabeth A Maher, Keith L Ligon, et al.
Magnetic Resonance in Medicine
|
February 1, 2020
In vivo MRS measurement of 2-hydroxyglutarate in patient-derived IDH-mutant xenograft mouse models versus glioma patients
Vivek Tiwari, Tomoyuki Mashimo, Zhongxu An, et al.
NMR in Biomedicine
|
March 16, 2012
Metabolism of [U-13 C]glucose in human brain tumors in vivo
Elizabeth A Maher, Isaac Marin-Valencia, Robert M Bachoo, et al.
Journal of Neuropathology and Experimental Neurology
|
April 30, 2019
Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival
Timothy E Richardson, Seema Patel, Jonathan Serrano, et al.
Journal of Neuro-Oncology
|
February 13, 2014
High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas
Kimmo J Hatanpaa, Tianshen Hu, Vamsidhara Vemireddy, et al.
Cell Metabolism
|
August 28, 2018
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
Kevin D Courtney, Divya Bezwada, Tomoyuki Mashimo, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2010
The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth
Calin O Marian, Steve K Cho, Brian M McEllin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening
Pasi A Jänne, Ana M Borras, Yanan Kuang, et al.
Cancer Research
|
November 23, 2006
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities
Elizabeth A Maher, Cameron Brennan, Patrick Y Wen, et al.
Journal of Neuro-Oncology
|
April 20, 2017
Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis
Timothy E Richardson, Matija Snuderl, Jonathan Serrano, et al.
Cancer Cell
|
June 28, 2002
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis
Robert M Bachoo, Elizabeth A Maher, Keith L Ligon, et al.
Magnetic Resonance in Medicine
|
February 1, 2020
In vivo MRS measurement of 2-hydroxyglutarate in patient-derived IDH-mutant xenograft mouse models versus glioma patients
Vivek Tiwari, Tomoyuki Mashimo, Zhongxu An, et al.
NMR in Biomedicine
|
March 16, 2012
Metabolism of [U-13 C]glucose in human brain tumors in vivo
Elizabeth A Maher, Isaac Marin-Valencia, Robert M Bachoo, et al.
Journal of Neuropathology and Experimental Neurology
|
April 30, 2019
Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival
Timothy E Richardson, Seema Patel, Jonathan Serrano, et al.
Journal of Neuro-Oncology
|
February 13, 2014
High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas
Kimmo J Hatanpaa, Tianshen Hu, Vamsidhara Vemireddy, et al.
Cell Metabolism
|
August 28, 2018
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
Kevin D Courtney, Divya Bezwada, Tomoyuki Mashimo, et al.
Page
of 6